News
Akadeum Life Sciences Announces Early-Access Launch of Large-Scale Cell Isolation Kit for Leukopaks
September 2022 Share
Akadeum’s microbubble technology allows scientists to effortlessly process up to twice as many leukopaks in as little as one-third the time of traditional methods, increasing throughput and optimizing processes ANN ARBOR, Mich., Sept. 21, 2022 — Akadeum Life Sciences, Inc., a global leader in buoyancy-based cell separation technology, announces a new early access program launch of an industry-first: the Microbubble Leukopak Human T Cell Isolation Kit. This new research use-only kit …
Akadeum Life Sciences Announces New Dead Cell Removal Kit Using Microbubble Technology
August 2022 Share
This new buoyant separation method creates a more effective way for researchers to use valuable samples with a higher retention rate of viable cells than current magnetic techniques Ann Arbor, MI – August 4, 2022 – Akadeum Life Sciences, Inc.—a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics, and cell and molecular research for human health and life sciences—announces today the launch of their Dead Cell Removal …
Akadeum Granted Patent for Buoyancy-Based Cell Separation “Microbubble” Technology
June 2022 Share
The patent bolsters Akadeum’s intellectual property and protects its current and future roster of buoyant separation products and applications ANN ARBOR, Mich., June 20, 2022 — Akadeum Life Sciences, Inc., a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics, and cell and molecular research for human health and life sciences, today announces a patent issuance for its proprietary method of buoyancy-based cell sorting (BACS ™) technologies from biological fluid …
Akadeum Unveils Cell Separation Product Expansion at American Association of Immunologist Meeting
May 2022 Share
Akadeum to showcase high-purity, high-yield isolation of Human B cells without the need for a column or magnet ANN ARBOR, Mich., May 06, 2022 — Akadeum Life Sciences, Inc.—a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics and cell and molecular research for human health and life sciences—today announced the expansion of its cell separation product portfolio with a new human B cell isolation product and updated …
Akadeum’s First Rising Innovators Research Award Recipient
December 2021 Share
Akadeum is thrilled to announce the first recipient of the Rising Innovators Research Award! Congratulations to Giselle Borges e Soares from Dr. Katherine Wall’s Laboratory at the University of Toledo. Giselle used Akadeum’s Mouse CD4+ T Cell Isolation Kit in the course of her research, obtaining 95-97% purity with ease. The success of downstream experiments is dependent upon the quality of the CD4+ T cell fraction, and by using Akadeum’s …
Akadeum’s Mouse B Cell Isolation Kit Used in New Research
November 2021 Share
Akadeum’s Mouse B Cell Isolation Kit was used in an article recently published in Cell Reports: Negative feedback by NUR77/Nr4a1 restrains B cell clonal dominance during early T-dependent immune responses Jeremy F. Brooks, Corey Tan, James L. Mueller, Kenta Hibiya, Ryosuke Hiwa, Vivasvan Vykunta, Julie Zikherman Cell Reports, Volume 36, Issue 9, 2021, 109645, ISSN 2211-1247 https://doi.org/10.1016/j.celrep.2021.109645 We would like to extend our heartfelt congratulations to the research team on …
Akadeum Life Sciences, Inc. Raises $17.5M Financing Round Led by Arboretum Ventures
October 2021 Share
Akadeum Life Sciences closes an oversubscribed round and plans to expand commercialization of proprietary biological separation platform. Dan Kidle, Managing Partner at Arboretum Ventures, joins Akadeum board of directors. October 12, 2021, Ann Arbor, MI – Akadeum Life Sciences, Inc., today announced the closing of an oversubscribed $17.5 million Series B financing led by Arboretum Ventures. Investors in the round also included Beringea, Agilent Technologies (NYSE:A), Lifespan Ventures, BlueStone Venture …
New Researcher Spotlight from Harvard: Using Akadeum’s Human CD4+ T Cell Isolation
August 2021 Share
A research group led by Professor Georg Lauer at Massachusetts General Hospital and the Harvard Medical School recently used Akadeum’s Human CD4+ T Cell Isolation Kit to obtain high purity enrichment of viable, healthy human CD4+ T cells. Dr. Hannah Drescher, a postdoctoral associate in the laboratory of Dr. Lauer, used the Akadeum CD4+ T Cell Isolation Kit in the course of their work in understanding the correlates of immune protection from chronic viral …
Enrichment of iNKT cells from Mouse Splenocyte Preps Following Depletion of Erythrocytes and B220+ B Cells
June 2021 Share
New Poster from Akadeum, in collaboration with Albert Einstein College of Medicine: Enhanced Enrichment of iNKT cells from Mouse Splenocyte Preps Following Gentle and Rapid Depletion of Erythrocytes and B220+ B Cells with Akadeum’s BACS Microbubbles Akadeum was honored to present a poster at this year’s CYTO Virtual Interactive 2021 in collaboration with Albert Einstein College of Medicine that showcases a novel and groundbreaking use for our revolutionary microbubble technology. …
Gene Expression Poster: Multiplexed Depletion of Cells From Whole Blood Samples Using BACS to Enrich CD4+ Target Cells
June 2021 Share
New Poster from Akadeum, in collaboration with Fluidigm: Multiplexed Depletion of Cells from Whole Blood Samples Using Buoyancy-Activated Cell Sorting (BACS) to Enrich CD4+ Target Cells for Single Gene Expression Analysis Akadeum was honored to present a poster at this year’s CYTO Virtual Interactive 2021 in collaboration with Fluidigm that showcases a novel and groundbreaking multiplexed use for our revolutionary microbubble technology. Single cell sequencing analysis requires viable, highly-purified cells …